New Pathways Identified to Reduce Pain and Depressive Symptoms in Fibromyalgia

New research has identified potential pathways that could lessen the pain and depressive symptoms experienced by people with fibromyalgia, a chronic condition that affects between 2 % and 6 % of the global population. The study highlights that fibromyalgia is marked by widespread, persistent pain, often accompanied by fatigue, sleep disturbances, cognitive difficulties, and affective symptoms.

Despite the high prevalence of fibromyalgia—particularly among women—scientists still do not fully understand the mechanisms that drive the disease’s development and persistence. The identification of these new pathways offers a promising avenue for developing more targeted treatments, though further investigation is needed to confirm their effectiveness and safety.

Fibromyalgia affects 2 % to 6 % of the global population, is characterized by widespread pain, fatigue, sleep disturbances, cognitive difficulties, and affective symptoms, and its underlying mechanisms remain incompletely understood.